In their classification system, Tervaert et al. 1 divide diabetic nephropathy into four classes based on the presence of what they consider to be increasingly serious glomerular lesions ().The ...

The following is a summary of “Steroid-resistant nephrotic syndrome due to renal-limited thrombotic microangiopathy and ...

Membranous nephropathy is a kidney disease where the filters or glomeruli inside of the kidneys become thickened and damaged.

Diabetic nephropathy is the leading cause of kidney disease in patients starting renal replacement therapy and affects ~40% of type 1 and type 2 diabetic patients. It increases the risk of death ...

We report the case of a woman presenting with uremic symptoms related to obstructive nephropathy from malacoplakia involving both ureters and the bladder. This case report illustrates malacoplakia ...

IgA nephropathy (IgAN) is an autoimmune kidney disease driven by immune cells that express a protein called CD38 on their ...

Patients with IgA nephropathy and severe proteinuria have a high lifetime risk of kidney failure. New research findings on the efficacy and safety of the selective endothelin type A receptor ...

Table 1. Diabetic Nephropathy Stages: Cutoff Values of Urine Albumin for Diagnosis and Main Clinical Characteristics Stages Albuminuria cutoff values (ref. 14) Clinical characteristics (ref. no.) ...

Immunoglobin A nephropathy (also known as IgAN or Berger's disease) is a rare kidney disease that occurs when your immune ...

Breakthrough status for nephropathy drug lifts Omeros The FDA has given breakthrough therapy designation to OMS721, a new treatment for the rare kidney disease immunoglobulin A (IgA) nephropathy.

Scientist develop new equation for detecting hyperfiltration that incorporates age but not body surface area. Read more!

Renalys Pharma, Inc. (Headquarters: Chuo-ku, Tokyo; "Renalys Pharma") announced today that it has completed patient enrollment for its registrational Phase III clinical trial of sparsentan for the ...